PL
Publications
126
Views
53,385
Downloads
9,046
Supervised works
5
Items per page
1 - 126 of 126
Title Published in Access level OA Policy Year Views Downloads
Systemic cytokines related to memory function 6-9 months and 12-15 months after SARS-CoV-2 infectionScientific reports
accessLevelPublic
2024 9 27
High-dose glucocorticoids in COVID-19 patients with acute encephalopathy: clinical and imaging findings in a retrospective cohort studyJournal of neural transmission
accessLevelPublic
2024 51 39
Persistence and emergence of new neuropsychological deficits following SARS-CoV-2 infection : A follow-up assessment of the Geneva COVID-COG cohortJournal of global health
accessLevelPublic
2024 25 18
Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG CohortArchives of clinical neuropsychology
accessLevelPublic
2023 398 197
Brain functional connectivity alterations associated with neuropsychological performance 6–9 months following SARS‐CoV ‐2 infectionHuman brain mapping
accessLevelPublic
2023 199 41
Acute TNFα levels predict cognitive impairment 6-9 months after COVID-19 infectionPsychoneuroendocrinology
accessLevelPublic
2023 163 54
Personality as a Predictor of Disability in Multiple SclerosisArchives of clinical neuropsychology
accessLevelPublic
2023 203 87
Markers of limbic system damage following SARS-CoV-2 infectionBrain communications
accessLevelPublic
2023 202 43
Utilité clinique des genome boards pour les maladies génétiques complexesRevue médicale suisse
accessLevelPublic
2023 136 10
Paroxysmal painful tonic spasms in neuromyelitis optica spectrum disordereNeurologicalSci
accessLevelPublic
2023 16 11
Obstructive sleep apnea: a major risk factor for COVID-19 encephalopathy?BMC neurology
accessLevelPublic
2023 55 46
Multicentric evaluation of a specific intrathecal anti-Treponema pallidum IgG index as a diagnostic biomarker of neurosyphilis: results from a retro-prospective case–control studySexually transmitted infections
accessLevelRestricted
2023 125 0
Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosisJAMA neurology
accessLevelRestricted
2023 97 0
c-Met+ Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor ModelsBiomedicines
accessLevelPublic
2023 7 7
Paraneoplastic Autoimmune Limbic Encephalitis Associated with an Atypical Carcinoid Tumor of the Lung : A Case ReportCase reports in neurology
accessLevelPublic
2023 92 35
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis PatientsJournal of magnetic resonance imaging
accessLevelPublic
2023 70 27
Monocytosis in the acute phase of SARS-CoV-2 infection predicts the presence of anosognosia for cognitive deficits in the chronic phaseBrain, behavior, & immunity. Health
accessLevelPublic
2022 162 31
Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumabJAMA neurology
accessLevelPublic
2022 196 118
Prognostic biomarkers in primary progressive multiple sclerosis : Validating and scrutinizing multimodal evoked potentialsClinical neurophysiology
accessLevelPublic
2022 7 7
Long COVID neuropsychological deficits after severe, moderate or mild infectionClinical and translational neuroscience
accessLevelPublic
2022 500 292
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple SclerosisJAMA neurology
accessLevelPublic
2022 190 84
Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyClinical infectious diseases
accessLevelPublic
2022 172 29
Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant?Brain communications
accessLevelPublic
2022 329 97
Answer to Letter to the Editor: High-resolution Black Blood Vessel Wall Imaging in COVID-19 Encephalopathy-is it Really Endotheliitis?Clinical neuroradiology
accessLevelPublic
2022 134 32
The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19Neurodegenerative diseases
accessLevelPublic
2022 73 82
CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammationJournal of neuroinflammation
accessLevelPublic
2022 175 71
Intrathecal Synthesis Index of Specific Anti-Treponema IgG: a New Tool for the Diagnosis of NeurosyphilisMicrobiology spectrum
accessLevelPublic
2022 169 122
Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDPNeurology: Neuroimmunology & Neuroinflammation
accessLevelPublic
2021 821 142
Rabies vaccination and multiple sclerosis relapse: A retrospective cohort studyMultiple Sclerosis and Related Disorders
accessLevelPublic
2021 254 107
COVID‐19 encephalopathy: Clinical and neurobiological featuresJournal of Medical Virology
accessLevelPublic
2021 274 343
c-Met enforces proinflammatory and migratory features of human activated CD4+ T cellsCellular & Molecular Immunology
accessLevelPublic
2021 242 163
Live vaccines and immunosuppressive monoclonal antibodies: weighing up the benefit-risk assessment for natalizumabJournal of Travel Medicine
accessLevelRestricted
2021 180 1
C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathyJournal of neural transmission
accessLevelPublic
2021 312 72
Neuropathie des petites fibres dans les maladies autoimmunes systémiquesRevue médicale suisse
accessLevelRestricted
2021 793 1
Does Endothelial Vulnerability in OSA Syndrome Promote COVID-19 Encephalopathy?Chest
accessLevelPublic
2021 138 36
Cerebrovascular Complications and Vessel Wall Imaging in COVID-19 Encephalopathy—A Pilot StudyClinical Neuroradiology
accessLevelPublic
2021 248 108
Cerebrospinal Fluid Features in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reverse Transcription Polymerase Chain Reaction (RT-PCR) Positive PatientsClinical infectious diseases
accessLevelPublic
2021 203 133
Update in immunosuppressive therapy of myasthenia gravisAutoimmunity reviews
accessLevelPublic
2021 7 0
Encéphalopathie aiguë et Covid-19: hypothèses physiopathologiquesRevue médicale suisse
accessLevelPublic
2021 200 182
Management of patients with generalised myasthenia gravis and COVID-19 : four case reportsJournal of neurology, neurosurgery and psychiatry
accessLevelRestricted
2020 6 0
Unusual Microbleeds in Brain MRI of Covid-19 PatientsJournal of Neuroimaging
accessLevelPublic
2020 831 406
Risk of MS relapse after yellow fever vaccination: A self-controlled case seriesNeurology: Neuroimmunology & Neuroinflammation
accessLevelPublic
2020 197 60
SARS‐CoV‐2 and Guillain–Barré syndrome : AIDP variant with a favourable outcomeEuropean journal of neurology
accessLevelPublic
2020 15 23
COVID-19-related encephalopathy responsive to high-dose glucocorticoidsNeurology
accessLevelRestricted
2020 181 1
Serum neurofilament light chains in MS: Association with the Timed Up and GoNeurology Neuroimmunology & Neuroinflammation
accessLevelPublic
2020 203 59
IL-8 as a potential biomarker in Guillain-Barre SyndromeEuropean Cytokine Network
accessLevelRestricted
2019 244 1
Encephalitis and meningoencephalitis: chasing the culpritClinical Microbiology and Infection
accessLevelPublic
2019 269 106
Pachymeningitis with optic neuropathy associated with extrapulmonary tuberculosis and secondary antiphospholipid syndromeMultiple Sclerosis and Related Disorders
accessLevelRestricted
2019 351 0
AQP4 antibody-positive NMO spectrum disorder associated with Takayasu arteritisJournal of the Neurological Sciences
accessLevelRestricted
2019 267 1
Diagnostic tools for immune causes of encephalitisClinical Microbiology and Infection
accessLevelRestricted
2019 376 2
Fulminant multifocal relapse in a fingolimod-treated multiple sclerosis patientMultiple Sclerosis and Related Disorders
accessLevelRestricted
2019 400 2
In-vivo gp100-specific Cytotoxic CD8+ T Cell Killing AssayBio-protocol
accessLevelPublic
2018 256 146
Syndrome de Guillain-BarréRevue médicale suisse
accessLevelPublic
2018 626 690
Activation of human B cells negatively regulates TGF-β1 productionJournal of Neuroinflammation
accessLevelPublic
2017 550 202
Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patientsJournal of Neuroinflammation
accessLevelPublic
2017 526 198
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisAnnals of Neurology
accessLevelRestricted
2017 570 0
Does fear of falling predict gait variability in multiple sclerosis?Journal of the Neurological Sciences
accessLevelRestricted
2017 593 0
Gait stability in patients treated by fingolimod: A longitudinal pilot study on 9 patients with multiple sclerosisJournal of the Neurological Sciences
accessLevelRestricted
2017 635 3
Gait Profile Score in multiple sclerosis patients with low disabilityGait & Posture
accessLevelRestricted
2017 534 1
Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytesEMBO Reports
accessLevelRestricted
2017 553 4
Upper limb movement analysis during gait in multiple sclerosis patientsHuman movement science
accessLevelRestricted
2017 517 0
[Paraneoplastic neurological syndromes: an update]Revue médicale suisse
accessLevelRestricted
2016 491 0
Sclérose en plaques de forme primaire progressive : un traitement se révèle enfin efficaceRevue médicale suisse
accessLevelRestricted
2016 567 8
Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigenActa neuropathologica
accessLevelRestricted
2016 520 0
Multiple sclerosis relapse mimicking a transient ischemic attackMultiple sclerosis and related disorders
accessLevelRestricted
2016 555 1
Postural control is associated with cognition and fear of falling in patients with multiple sclerosisJournal of neural transmission
accessLevelRestricted
2016 484 0
Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disabilityJournal of neural transmission
accessLevelRestricted
2016 617 1
Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of fallingJournal of neural transmission
accessLevelRestricted
2016 542 0
Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomesEuropean journal of clinical investigation
accessLevelRestricted
2016 584 6
B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammationScientific reports
accessLevelPublic
2016 585 235
Meningoencephalitis with microinfarcts in early neuroborreliosisNeuroradiology
accessLevelRestricted
2016 514 1
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patientsMultiple sclerosis
accessLevelRestricted
2015 617 1
Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MSNeurology® neuroimmunology & neuroinflammation
accessLevelRestricted
2015 450 0
Minimal supportive treatment in natalizumab-related PML in a MS patientJournal of neurology, neurosurgery and psychiatry
accessLevelRestricted
2015 505 0
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-upJournal of neuroimmunology
accessLevelRestricted
2015 532 1
Hepatocyte growth factor: A regulator of inflammation and autoimmunityAutoimmunity reviews
accessLevelRestricted
2015 511 0
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal studyNeurology® neuroimmunology & neuroinflammation
accessLevelPublic
2015 458 300
Transient gadolinium leakage in natalizumab-treated multiple sclerosisJournal of neurology, neurosurgery and psychiatry
accessLevelRestricted
2015 426 0
Successful long-term ambulatory norepinephrine infusions in a patient with pure autonomic failureClinical autonomic research
accessLevelRestricted
2015 488 0
Cannabinoïdes médicaux dans les douleurs chroniques : aspects pharmacologiquesRevue médicale suisse
accessLevelRestricted
2015 669 5
Glatiramer acetate treatment negatively regulates type I interferon signalingNeurology® neuroimmunology & neuroinflammation
accessLevelRestricted
2015 437 1
Multifocal motor neuropathy with high titers of anti-MAG antibodiesJournal of the peripheral nervous system
accessLevelRestricted
2014 515 0
Update on multiple sclerosis treatmentsSchweizerische medizinische Wochenschrift
accessLevelRestricted
2014 471 1
Fingolimod in a patient with Wolff-Parkinson-White syndromeMultiple sclerosis
accessLevelRestricted
2014 413 0
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cellsJournal of neuroimmunology
accessLevelRestricted
2014 513 0
Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cellsThe Journal of immunology
accessLevelRestricted
2014 665 3
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis PatientsEuropean neurology
accessLevelRestricted
2014 675 4
18FDG-PET-CT: an imaging biomarker of high-risk carotid plaques. Correlation to symptoms and microembolic signalsStroke
accessLevelRestricted
2014 667 3
Walking while talking in patients with multiple sclerosis: the impact of specific cognitive loadsNeurophysiologie clinique
accessLevelRestricted
2014 614 3
Traitement de la sclérose en plaques : nouveautés et complicationsRevue médicale suisse
accessLevelRestricted
2013 438 0
Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseasesPloS one
accessLevelPublic
2013 699 427
Neuropathies associées aux paraprotéinémies (gammapathies monoclonales)Revue médicale suisse
accessLevelRestricted
2013 407 0
Maladies auto-immunes neuromusculaires : diagnostic et prise en chargeRevue médicale suisse
accessLevelRestricted
2013 438 0
The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activityJournal of neuroinflammation
accessLevelPublic
2013 599 338
Neuroborréliose, méningo-encéphalite verno-estivale et neurosyphilisRevue médicale suisse
accessLevelPublic
2013 387 191
Nogo-A downregulation improves insulin secretion in miceDiabetes
accessLevelPublic
2013 667 270
[Head inflammation]Revue médicale suisse
accessLevelRestricted
2013 383 0
Adapted timed up and go: a rapid clinical test to assess gait and cognition in multiple sclerosisEuropean neurology
accessLevelRestricted
2012 705 0
IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitisJournal of neuroinflammation
accessLevelPublic
2012 670 311
Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patientsPloS one
accessLevelPublic
2012 653 254
Hypereosinophilia in patients with multiple sclerosis treated with natalizumabNeurology
accessLevelRestricted
2011 687 0
Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosisJournal of neuroinflammation
accessLevelPublic
2011 616 302
Antibody response in MOG35–55 induced EAEJournal of neuroimmunology
accessLevelPublic
2011 724 605
Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition?Archives of neurology
accessLevelRestricted
2011 642 0
Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of actionCNS drugs
accessLevelRestricted
2011 558 0
Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in childrenMultiple sclerosis
accessLevelRestricted
2011 556 0
Biomarqueurs en neuroimmunologieRevue médicale suisse
accessLevelRestricted
2011 495 1
Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune diseasePloS one
accessLevelPublic
2010 704 668
VGKC antibody-associated encephalitis, microbleeds and progressive brain atrophyJournal of neurology
accessLevelPublic
2010 641 296
Glatiramer acetate triggers PI3Kdelta/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytesProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
2010 655 0
Behaviorally spontaneous confabulation in limbic encephalitis: the roles of reality filtering and strategic monitoringJournal of the International Neuropsychological Society
accessLevelRestricted
2010 661 0
MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunityThe Journal of experimental medicine
accessLevelRestricted
2010 653 1
Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cellsProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
2010 684 0
Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosisProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
2009 611 0
Peripheral autoimmune neuropathy assessed using corneal in vivo confocal microscopyArchives of neurology
accessLevelRestricted
2009 628 0
Anomalous brain dominance and the immune system: do left-handers have specific immunological patterns?Brain and cognition
accessLevelRestricted
2009 627 0
Increasing the diagnostic value of evoked potentials in multiple sclerosis by quantitative topographic analysis of multichannel recordingsJournal of clinical neurophysiology
accessLevelRestricted
2009 652 2
Autoanticorps en neurologie : implications cliniquesRevue médicale suisse
accessLevelRestricted
2009 528 0
Syndrome of transient headache and neurological deficits with CSF lymphocytosis (HaNDL) associated with recent human herpesvirus-6 infectionCephalalgia
accessLevelRestricted
2009 663 1
Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patientsJournal of neuroimmunology
accessLevelRestricted
2008 606 0
Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine modelInternational immunology
accessLevelRestricted
2008 601 1
Human herpesvirus-6 variant A encephalomyelitisNeurology
accessLevelRestricted
2008 631 0
Autoantibodies in inflammatory demyelinating diseases of the central nervous systemSchweizerische medizinische Wochenschrift
accessLevelRestricted
2008 571 4
TNF-alpha and psychologically stressful events in healthy subjects: potential relevance for multiple sclerosis relapseBehavioral neuroscience
accessLevelRestricted
2002 449 0
Encéphalopathie complexe, transitoire et récidivante après résection étendue de l'intestin grêle. Responsabilité du D-LactateRevue neurologique
2001 542 0
Lower limb corticobasal degenerationEuropean neurology
accessLevelRestricted
2000 542 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack